CADM1 and hepatocellular carcinoma: MiR-194 inhibits CADM1 protein level expression in hepatocellular carcinoma (HCC) by inhibiting mRNA translation of CADM1, and promoting proliferation, invasion, migration, and cell cycle progression of HCC cells by inhibition of CADM1 [104].